Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 5/20 | 0.39 |
| ▸ | SLC22A16 | Q86VW1 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 3/20 | 0.34 |
| ▸ | CHRM2 | P08172 | 2/20 | 0.34 |
| ▸ | CHRM4 | P08173 | 2/20 | 0.34 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.34 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.34 |
| ▸ | GSTP1 | P09211 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 2/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.33 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.33 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.33 |
| ▸ | GALR3 | O60755 | 1/20 | 0.33 |
| ▸ | BLM | P54132 | 1/20 | 0.33 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.31 |
| ▸ | ATM | Q13315 | 1/20 | 0.31 |
| ▸ | USP2 | O75604 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL270107 | 0.98 | MAPT (0.42) | MAPTSLC22A16TSHRCHRM2CHRM4 | |
| Bromide SCHEMBL11520163 | 0.98 | MAPT (0.38) | MAPTSLC22A16TSHRCHRM2CHRM4 | |
| Phosphoric Acid SCHEMBL8763242 | 0.93 | MAPT (0.35) | MAPTSLC22A16TSHRCHRM2CHRM4 | |
| Sulfuric Acid SCHEMBL11519852 | 0.93 | MAPT (0.35) | MAPTSLC22A16TSHRCHRM2CHRM4 | |
| SCHEMBL20335453 | 0.88 | TSHR (0.39) | MAPTTSHRGSTP1LMNASMN1; SMN2 | |
| Hydrochloric Acid SCHEMBL10839320 | 0.86 | MAPT (0.34) | MAPTSLC22A16TSHRSMN1; SMN2USP2 | |
| Hydrochloric Acid SCHEMBL8777402 | 0.84 | HCAR2 (0.34) | MAPTTSHRGSTP1HCAR2ATM | |
| SCHEMBL23581952 | 0.82 | TSHR (0.35) | MAPTTSHRGSTP1SMN1; SMN2HCAR2 | |
| SCHEMBL2868662 | 0.82 | KDM4E (0.43) | TSHRGSTP1LMNAHCAR2ATM | |
| SCHEMBL650096 | 0.82 | HCAR2 (0.36) | MAPTTSHRGSTP1LMNASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 55 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1173878-B1 | PROBES FOR A GAS PHASE ION SPECTROMETER | BIO RAD LABORATORIES (US) | 2011-04-06 | — | — | EP | claimed |
| US-20080031846-A1 | Compositions with enhanced antimicrobial efficacy against acanthamoebae | BORAZJANI ROYA | 2008-02-07 | — | — | US | claimed |
| EP-1852133-A2 | Compositions with enhanced antimicrobial efficacy against acanthamoebae | BAUSCH & LOMB INCORPORATED (US) | 2007-11-07 | — | — | EP | claimed |
| EP-0920487-B1 | COMPOSITION AND METHOD FOR INHIBITING THE DEPOSITION OF PROTEIN ON CONTACT LENS | BAUSCH & LOMB (US) | 2003-04-09 | — | — | EP | claimed |
| EP-0834777-B1 | Cationic toner processes | XEROX CORP (US) | 2001-01-03 | — | — | EP | claimed |
| US-6096138-A | IMMERSION IN AQUEOUS SOLUTION OF POLYQUATERNARY AMMONIUM SALT CATIONIC POLYMER | BAUSCH & LOMB INCORPORATED (US) | 2000-08-01 | — | — | US | claimed |
| EP-0371821-B1 | A process for the production of substituted acryloyloxyhydroxypropyltrialkylammonium chloride | RHONE POULENC SPEC CHIM (US) | 1994-05-25 | — | — | EP | claimed |
| US-4393939-A | Clay stabilization during oil and gas well cementing operations | HALLIBURTON SERVICES (US) | 1983-07-19 | — | — | US | claimed |
| US-20240218291-A1 | CONTACT LENS TREATING SOLUTION | JPMORGAN CHASE BANK, N.A., AS SUCCESSOR AGENT | 2024-07-04 | — | — | US | disclosed |
| WO-2024132271-A1 | CONTACT LENS TREATING SOLUTION | BAUSCH + LOMB IRELAND LIMITED (IE) | 2024-06-27 | — | — | WO | disclosed |
| US-20240166971-A1 | CONTACT LENS TREATING SOLUTION | JPMORGAN CHASE BANK, N.A., AS SUCCESSOR AGENT | 2024-05-23 | — | — | US | disclosed |
| WO-2024089166-A1 | CONTACT LENS TREATING SOLUTION | BAUSCH + LOMB IRELAND LIMITED (IE) | 2024-05-02 | — | — | WO | disclosed |
| WO-2023094265-A1 | METHOD FOR MAKING A PRESERVATIVE-FREE PACKAGED OPHTHALMIC DEVICE PRODUCT | BAUSCH + LOMB IRELAND LIMITED (IE) | 2023-06-01 | — | — | WO | disclosed |
| US-20230159202-A1 | METHOD FOR MAKING A PRESERVATIVE-FREE PACKAGED OPHTHALMIC DEVICE PRODUCT | JPMORGAN CHASE BANK, N.A., AS SUCCESSOR AGENT | 2023-05-25 | — | — | US | disclosed |
| EP-0371823-A1 | Crystalline 3-methacryloyloxy-2-hydroxypropyl-trimethylammonium chloride monomer | POLYPURE INC. (US) | 1990-06-06 | — | — | EP | disclosed |
| EP-0371823-A1 | Crystalline 3-methacryloyloxy-2-hydroxypropyl-trimethylammonium chloride monomer | POLYPURE INC. (US) | 1990-06-06 | — | — | EP | disclosed |
| EP-0371821-A1 | A process for the production of substituted acryloyloxyhydroxypropyltrialkylammonium chloride | RHONE-POULENC SPECIALTY CHEMICALS CO. (US) | 1990-06-06 | — | — | EP | disclosed |
| EP-0371822-A1 | Copolymers of 3-methacryloyloxy-2-hydroxypropyl trimethylammonium chloride monomer and vinyl monomer | S. N. F. (FR) | 1990-06-06 | — | — | EP | disclosed |
| EP-0253515-A2 | Fluorine containing soft contact lens hydrogels | OPTIMERS INC. (US) | 1988-01-20 | — | — | EP | disclosed |
| US-4663061-A | Metal-working oil composition | KAO CORPORATION (JP) | 1987-05-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080031846-A1 | Compositions with enhanced antimicrobial efficacy against acanthamoebae | LAGE3, PKD2, CUTA | MAPT 4211/4885SLC22A16 4514/4885TSHR 4655/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.